5 things to watch on the ASX 200 on Friday

The ASX 200 is expected to end the week with a small gain.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday, the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped into the red. The benchmark index fell 0.6% to 6,812.3 points.

Will the market be able to bounce back from this on Friday and end the week on a high? Here are five things to watch:

Business woman watching stocks and trends while thinking

Image Source: Getty Images

ASX 200 expected to edge higher

The Australian share market looks set to end the week on a mildly positive note despite another poor session on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open 12 points or 0.2% higher this morning. In late trade on the United States, the Dow Jones is down 0.55%, the S&P 500 is down 1%, and the NASDAQ is down 1.55%.

Oil prices fall

ASX 200 energy shares Beach Energy Ltd (ASX: BPT) and Woodside Energy Group Ltd (ASX: WDS) could end the week in the red following a poor night for oil prices. According to Bloomberg, the WTI crude oil price is down 2.6% to US$83.09 a barrel and the Brent crude oil price is down 2.6% to US$87.82 a barrel. Demand concerns weighed on oil prices.

ResMed quarterly update

The ResMed Inc (ASX: RMD) share price will be on watch today when the sleep treatment company releases its quarterly update. All eyes will be on management's commentary regarding the rise of wonder drugs like Ozempic. Concerns about these GLP-1 drugs are why the company's shares have been sold off in recent months.

Gold price edges lower

ASX 200 gold miners including Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could have a soft finish to the week after the gold price edged lower overnight. According to CNBC, the spot gold price is down 0.1% to US$1,993.6 an ounce. Strong US economic data put pressure on gold.

Allkem shares named as buy

Goldman Sachs believes Allkem Ltd (ASX: AKE) shares are undervalued. In response to the lithium miner's first-quarter update, the broker has reiterated its buy rating with a trimmed price target of $14.40. It said: "Long-term organic growth optionality remains undervalued."

Motley Fool contributor James Mickleboro has positions in Allkem and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Share Fallers

DroneShield shares tumble 17% as CEO exit revives leadership fears

Investors bank gains as DroneShield leadership reset unsettles sentiment...

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares

The team at Morgans has given its verdict on these popular shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Morgans names two ASX 200 shares to buy and one to sell this week

Let's see which shares Morgans is bullish and bearish on this week.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Broker Notes

Why beaten down CSL shares now offer 'long-term appeal'

A leading expert gives his outlook for CSL’s beaten down shares.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 compelling reasons to buy QBE shares today

A top expert forecasts more outperformance from QBE shares.

Read more »

Falling prices of oil demonstrated by a red arrow and barrels of oil.
Energy Shares

ASX shares to watch as oil price crashes

The turnaround in oil prices is a huge headwind for the ASX shares.

Read more »